FDA Warns Cosmetics Firm on Unapproved, Misbranded Drugs
The Food and Drug Administration has issued a warning letter to Lifetech Resources LLC regarding its manufacturing, distribution, and promotion of RapidLash Eyelash Renewal Serum, NeuLash Active Eyelash Technology, and NeuveauBrow Active Eyebrow Technology, which FDA states are unapproved and…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
misbranded drugs and violate provisions of the Federal Food, Drug, and Cosmetic Act. FDA urges LifeTech to take prompt action to correct the violations, and states that failure to promptly correct the violations may result in legal action, including seizure and injunction.